The development of new drugs or medical interventions is a meticulous process involving various stages to ensure safety, efficacy, and regulatory compliance. Central to this journey are the preclinical and clinical trial phases, which…
Continue Reading
What You Should Know:
– Mass General Brigham AI is spearheading the Healthcare AI Challenge, a multi-institutional initiative designed to assess the latest AI technologies in real-world healthcare scenarios.
– The virtual, interactive series of events…
Continue Reading
What You Should Know:
– Healthpilot, an AI-powered Medicare comparison platform, and Publix Supermarkets have joined forces to simplify the process of choosing Medicare plans for seniors.
– Publix Pharmacy customers can now access Healthpilot’s comparison…
Continue Reading
What You Should Know:
– Genesis Therapeutics, a company pioneering artificial intelligence (AI) technologies to create breakthrough medicines for patients, announced today a further equity investment from NVentures, NVIDIA’s venture capital arm.
– This investment is in addition…
Continue Reading
What You Should Know:
– Medeloop, a pioneering medical research platform, has secured $15.5M in Series A funding to further its mission of revolutionizing medical research through artificial intelligence (AI).
– The funding round was led…
Continue Reading
Taylor Wirth, Partner at Barnes & Thornburg
Life science companies, particularly those heavily invested in research and development, often face critical funding decisions. Should they pursue an initial public offering (IPO) to fuel their growth,…
Continue Reading
Dr. Srdjan Prodanovich, Dermatologist and Creator of EZDERM
Healthcare has never been more complex than it is today. There has been a rapid expansion of medical treatment options, increasingly stringent regulatory requirements, and an ever-evolving…
Continue Reading
What You Should Know:
– Bluespine, an AI-driven claims cost reduction platform for self-insured employers, has secured $7.2M in seed funding to address the pervasive issue of medical overbilling in the US healthcare system led…
Continue Reading
Krishna Subramanian, Co-Founder & COO at Komprise
In recent years, the healthcare industry has increasingly emphasized the importance of controlling costs, minimizing waste, and enhancing care outcomes. This focus is particularly urgent in California, where…
Continue Reading
Meghan Harrington, VP of Clinical Trial Financial Management at Medidata
Achieving diversity in clinical trials is crucial for developing effective and safe treatments for all populations. Yet, financial barriers often exclude underrepresented groups from participating,…
Continue Reading
